The importance of planning market access strategies at an early stage. There is an ever-increasing influence of payers in treatment decision-making processes. The commercial success of new pharmaceutical agents will therefore be heavily dependent on their market access position. In the past it was the norm to engage with regulators at an early stage of […]
Several clients have brought this review from McKinsey, the global management consultancy, to our attention over the last few weeks. It’s prompted us to reflect on the forecasting we conduct with our clients and put down our opinions on the value of the forecasting process. It also gives us the opportunity to listen to your […]
You can click here for our White Paper.
Sometimes a novel approach to working effectively comes along that really resonates. For groupH, Tony Schwartz and Catherine McCarthy’s tried and tested approach, published in the Harvard Business Review back in 2007, did just that. They described how organizations are demanding ever-higher performance from their workforces and that staff are trying to comply, by working […]
Recent initiatives are changing the dynamics in the Japanese pharmaceutical market. At one end of the spectrum, a trial process is rewarding innovation by exempting new drugs from biennial price cuts in return for investing in areas of unmet need, whilst other measures are speeding up drug approvals. At the other end, the need to […]
A new era of targeted oral therapies? Rheumatoid arthritis (RA) treatment options have expanded from conventional oral therapies like methotrexate, through the era of targeted injectable biologics and into a new dawn of targeted oral treatment. Xeljanz, Pfizer’s first-in-class JAK3 inhibitor (tofacitinib), was launched in the US in 2012 – the first oral therapy approved […]
Here at groupH, we are always looking for new ways to present information, data and concepts more cleanly and more concisely. We have found the following websites inspiring, and hope you do too: Beautiful: http://www.informationisbeautiful.net/tag/health/ Informative: (The Economist’s daily chart) http://www.economist.com/blogs/graphicdetail Scientific and Statistical: http://www.datavis.ca/gallery/bright-ideas.php Tools: http://www.idea.org/blog/2012/10/25/great-tools-for-data-visualization/
Favourable market conditions. The anti-obesity market is predicted to be worth $2.4 billion by 2021, growing 21% annually. High unmet need and advantageous epidemiological trends are key drivers. At first glance, the opportunity for new therapies seems considerable. Limited success for Pharma so far. For decades drug developers have had limited success in grabbing this […]
This Christmas, as in previous years, we have made donations to our chosen charities. We are supporting the UK charity Action MS. Action MS maintains a highly successful fund-raising programme that supports research into multiple sclerosis, and an extensive range of care and support services to people and families living with MS. In addition, this […]
Each year, at Christmas time, we donate a proportion of our operating profit to our two chosen charities. The decision to support charities was taken at the very outset of the formation of groupH. It’s simply something that we feel is the right thing to do, not just something to put in our Corporate Social […]
